Banyan Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$737K Sell
2,819
-100
-3% -$25.6K 0.32% 26
2026
Q2
$735K Sell
2,919
-200
-6% -$43K 0.32% 30
2026
Q1
$678K Hold
3,119
– – 0.29% 35
2025
Q4
$713K Hold
3,119
– – 0.31% 27
2025
Q3
$722K Buy
+3,119
New +$635K 0.33% 21

Other funds holding ABBV

Banyan Capital Management's ABBV Position: Q3 2026 in Review

Banyan Capital Management reduced its AbbVie (ABBV) stake by 3.4% in Q3 2026, selling an estimated $25.6K and leaving 2,819 shares worth $737K. The position accounts for 0.32% of the portfolio, ranked #26.

Banyan Capital Management first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Banyan Capital Management held 2,819 shares of AbbVie worth $737K as of Q3 2026.
  • Banyan Capital Management sold 100 AbbVie shares in Q3 2026, an estimated $25.6K.
  • AbbVie made up 0.32% of Banyan Capital Management's portfolio in Q3 2026, its #26 holding.
  • Banyan Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Banyan Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.